Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in Central African Republic

Central African Republic: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology was 5.3% in 2024. ▼ Falling

Latest (2024)
5.3%
Change on year
down 10.2%
World rank
1st
of 215 countries
All-time high
10.5%
in 2017
All-time low
5.3%
in 2024
Years of data
10
2015–2024

Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in Central African Republic, 2015–2024

02.557.5102015201920242015: 9.92016: 102017: 10.52018: 10.22019: 9.52020: 8.52021: 7.72022: 7.42023: 5.92024: 5.3

Source: United Nations Statistics Division, SDG Global Database.

Analysis

In 2024, prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in Central African Republic stood at 5.3%. That is the lowest value across all 10 years on record.

Compared with earlier readings it is down 10.2% on the previous year and down 46.5% over ten years.

Over the whole period, prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in Central African Republic peaked at 10.5% in 2017 and was at its lowest, 5.3%, in 2024.

That places Central African Republic 1st out of 215 countries with data for 2024, putting it in the top 10%.

Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in Central African Republic, year by year

Annual values for Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%) in Central African Republic, 2015 to 2024.
Year Value Change
2015 9.9%
2016 10.0% +1.0%
2017 10.5% +5.0%
2018 10.2% -2.9%
2019 9.5% -6.9%
2020 8.5% -10.5%
2021 7.7% -9.4%
2022 7.4% -3.9%
2023 5.9% -20.3%
2024 5.3% -10.2%

Averages by decade

DecadeAverage LowestHighest Years
2010s 10.0% 9.5% 10.5% 5
2020s 7.0% 5.3% 8.5% 5

Countries ranked near Central African Republic

  1. 1 Cabo Verde 0.7% compare
  2. 2 Democratic Republic of the Congo 1.4% compare
  3. 2 Somalia 4.0% compare
  4. 3 Gabon 3.2% compare
  5. 3 Niger 3.2% compare
  6. 3 Timor-Leste 1.0% compare
  7. 4 Viet Nam 0.9% compare

See the full ranking of 236 places →

More development goals data for Central African Republic

All data for Central African Republic →

Frequently asked questions

What is prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in Central African Republic?
Prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in Central African Republic was 5.3% in 2024, according to United Nations Statistics Division, SDG Global Database.
What is the highest prevalence of hepatitis b surface antigen (hbsag), 2026 methodology recorded in Central African Republic?
The highest recorded value was 10.5% in 2017.
What is the lowest prevalence of hepatitis b surface antigen (hbsag), 2026 methodology recorded in Central African Republic?
The lowest recorded value was 5.3% in 2024.
How does Central African Republic rank for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
Central African Republic ranks 1st out of 215 countries with data for 2024.
Is prevalence of hepatitis b surface antigen (hbsag), 2026 methodology rising or falling in Central African Republic?
Over the last ten years it is down 46.5%. The long-run trend across the full record is falling.
Where does this Central African Republic data come from?
The figures come from United Nations Statistics Division, SDG Global Database, published as part of Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 10 observations, free to reuse under UN SDG Global Database (open, attribution requested).

Share, cite or embed this page

Cite this page

Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in Central African Republic. Statizoid, drawing on United Nations Statistics Division, SDG Global Database. Retrieved 01 September 2026, from https://development-goals.statizoid.com/stat/prevalence-of-hepatitis-b-surface-antigen-hbsag-2026-methodology-percent/central-african-republic/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under UN SDG Global Database (open, attribution requested); please keep the attribution.

<a href="https://development-goals.statizoid.com/stat/prevalence-of-hepatitis-b-surface-antigen-hbsag-2026-methodology-percent/central-african-republic/">Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in Central African Republic</a> — Statizoid

About this data

Indicator
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%)
Source
United Nations Statistics Division, SDG Global Database
Licence
UN SDG Global Database (open, attribution requested)
Coverage
236 places, 2,360 data points, 2015–2024
Last refreshed